Re: Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate-and High-Risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-Third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG | AVESİS

Acıbadem Mehmet Ali Aydınlar Üniversitesi Akademik Veri Yönetim Sistemi

Re: Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate-and High-Risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-Third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG

Atıf İçin Kopyala

Brausi M., Oddens J., Sylvester R., Bono A., van de Beek C., van Andel G., ...Daha Fazla

JOURNAL OF UROLOGICAL SURGERY, cilt.2, sa.1, ss.41, 2015 (ESCI)

Yayın Türü: Makale / Editöre Mektup
Cilt numarası: 2 Sayı: 1
Basım Tarihi: 2015
Doi Numarası: 10.4274/jus.2015.01.004
Dergi Adı: JOURNAL OF UROLOGICAL SURGERY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI)
Sayfa Sayıları: ss.41
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet